Investigation of quality deviation in thiamine (vitamin B1) tablets due to suspect of therapeutic inefficacy in the treatment of neuropsychiatric conditions

Authors

DOI:

https://doi.org/10.22239/2317-269X.01249

Keywords:

Thiamine, Fiscal Analysis of Products, Quality Control, Alcoholism, Nervous System Diseases

Abstract

Introduction: Thiamine supplementation for alcohol-dependent patients is one of the most important strategies for treating alcohol withdrawal syndrome and preventing and treating more serious neurological related complications. Also, it is used as adjuvant treatment for neurological conditions in geriatric patients. A municipal sanitary surveillance service from São Paulo requested the analysis of batches of thiamine hydrochloride tablets after complaints of therapeutic inefficacy during treatment of distinct neuropsychiatric conditions. Objective: To check if the thiamine therapeutic inefficacy complaints were associated to the medications’ quality. Method: Fiscal analyses were performed including aspect, weight variation, identification and potency of thiamine hydrochloride, uniformity of unitary doses and dissolution. Results: There was no quality deviation in the medications, as all performed assays presented satisfactory results. Conclusions: The administration of quality medications is essential for obtaining expected clinical effects. Other factors not associated to the medication quality such as patients’ adherence to the treatment and poor oral absorption might be associated to the complaints.

Downloads

Download data is not yet available.

Author Biographies

  • Jaqueline Kalleian Eserian, Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz (IAL), São Paulo, SP

    Possui graduação em Farmácia - Faculdades Oswaldo Cruz (2008), mestrado (2011) e doutorado (2018) em Ciências pela Universidade Federal de São Paulo (Departamento de Psicobiologia). Atualmente é Pesquisador Científico do Instituto Adolfo Lutz. Possui experiência nas áreas de farmácia e saúde pública, com ênfase em medicamentos, atuando principalmente nos seguintes temas: fármacos psicoativos, controle de qualidade físico-químico e terapêutica medicamentosa.

  • Márcia Lombardo, Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz (IAL), São Paulo, SP

    Graduada em Farmácia pela Faculdade Oswaldo Cruz. Mestre em Fármaco e Medicamentos pela Universidade de São Paulo. Atualmente é Pesquisadora Científica do Instituto Adolfo Lutz e doutoranda em Ciências pela Universidade de São Paulo. Tem experiência nas áreas de bioquímica de produtos naturais e qualidade de medicamentos.

Published

2019-02-28

Issue

Section

Short communication

How to Cite

Investigation of quality deviation in thiamine (vitamin B1) tablets due to suspect of therapeutic inefficacy in the treatment of neuropsychiatric conditions. (2019). Health Surveillance under Debate: Society, Science & Technology , 7(1), 76-80. https://doi.org/10.22239/2317-269X.01249